Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
DXCM
TEVA
Add up to 3 more stocks
DXCM
DexCom, Inc.
+1.11%
$90.28+0.99Delayed quote: Aug 28, 2026, 12:44 PM EDT
Market Cap
$34.07B
52W Range
$54.11 - $92.59
TEVA
Teva Pharmaceutical Industries Limited
-2.68%
$36.61-1.01Delayed quote: Aug 28, 2026, 12:44 PM EDT
Market Cap
$42.64B
52W Range
$17.94 - $38.37
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 35.29 | 62.70 |
| Forward P/E | 33.47 | 18.80 |
| P/B Ratio | 13.35 | 5.73 |
| P/S Ratio | 7.04 | 2.57 |
| P/FCF Ratio | 24.90 | 32.96 |
| EV/EBITDA | 25.14 | 19.40 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 62.5% | 52.5% |
| Operating Margin | 22.9% | 11.4% |
| Net Margin | 20.1% | 4.1% |
| ROE | 38.1% | 9.1% |
| ROA | 15.5% | 1.8% |
| ROIC | 21.7% | 6.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.73 | 0.88 |
| Quick Ratio | 1.43 | 0.67 |
| Debt/Equity | 0.53 | 2.18 |
| Interest Coverage | 49.83 | 2.35 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes metrics that are structurally not meaningful for a company's sector (e.g. EV multiples, free-cash-flow ratios, and working-capital ratios for banks and insurers). Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.